Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

RUBICON

  • FDA Approval
  • Dec. 19, 2022, 12:42 UTC
  • 34
  • 0 comments

FDA approve BUPRENORPHINE HYDROCHLORIDE

Comment Full text

INDIVIOR INC

  • FDA Approval
  • Dec. 19, 2022, 12:42 UTC
  • 25
  • 0 comments

FDA approve BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE

Comment Full text

WYETH PHARMS

  • FDA Approval
  • Dec. 19, 2022, 12:42 UTC
  • 24
  • 0 comments

FDA approve PIPERACILLIN SODIUM; TAZOBACTAM SODIUM

Comment Full text

PIRAMAL CRITICAL

  • FDA Approval
  • Dec. 19, 2022, 12:42 UTC
  • 27
  • 0 comments

FDA approve CISATRACURIUM BESYLATE

Comment Full text

INDIVIOR INC

  • FDA Approval
  • Dec. 17, 2022, 14:58 UTC
  • 34
  • 0 comments

FDA approve RISPERIDONE

Comment Full text

WYETH PHARMS

  • FDA Approval
  • Dec. 17, 2022, 14:58 UTC
  • 24
  • 0 comments

FDA approve PIPERACILLIN SODIUM; TAZOBACTAM SODIUM

Comment Full text

BAXTER HLTHCARE CORP

  • FDA Approval
  • Dec. 17, 2022, 14:58 UTC
  • 24
  • 0 comments

FDA approve BENDAMUSTINE HYDROCHLORIDE

Comment Full text

KINDOS PHARMA CO LTD

  • FDA Approval
  • Dec. 17, 2022, 14:58 UTC
  • 30
  • 0 comments

FDA approve PLERIXAFOR

Comment Full text

HOSPIRA

  • FDA Approval
  • Dec. 17, 2022, 14:58 UTC
  • 26
  • 0 comments

FDA approve BENDAMUSTINE

Comment Full text

J AND J CONSUMER INC

  • FDA Approval
  • Dec. 17, 2022, 14:58 UTC
  • 26
  • 0 comments

FDA approve FAMOTIDINE

Comment Full text
  • Previous
  • 920
  • 921
  • 922
  • 923
  • 924
  • Next

Search

News categories

  • Technical Exchange News(12263)
  • Event(6229)
  • SEC News(267573)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(155715)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin